Scientists reprogram Patients' own cells to hunt HIV
NCT ID NCT03617198
Summary
This early-stage study is testing a new approach to treating HIV. Researchers collect a patient's own immune cells, genetically modify them to better target HIV, and then infuse them back into the body. The main goals are to check if this process is safe and to see if the modified cells can help control the virus, especially when regular HIV medication is paused.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.